Max
@MaxKrummel
Prof @ucsf @immunox, Immunologist,Immunotherapy pioneer,believer in the power of curiosity,striving to make sense of complicated things, typically enthusiastic.
Interested in the evolution of how we share and curate our science? For those coming to CICON24, check out @beiyun_liu and this poster. For those not there, try this out, participate, enjoy helping science and your colleagues move forward: solvingfor.org/campaigns-data…
We are grateful to @FounderyInc. for their generosity and support of four ImmunoX fellows and for leading the charge in developing an innovative way to support the education of future scientists and ensure diversity, equity, and inclusion in science. #TheFutureisBright
🙏RT 📅Abstract deadline DC2024 Barcelona 30th May 🚨 SUBMIT NOW 👇 dc2024barcelona.com/index.php/abst… 🔬34 short talks + posters!!! 🔝🌍speakers dc2024barcelona.com/index.php/spea… support by: @SEinmunologia @SCImmunologia @EuMacDcSoc Sponsors: 🥇@miltenyibiotec 🥈@inmunotek 🥉@BioLegend @EMBO
Looking forward to welcoming everyone to beautiful Killarney for #KSMyeloidTargets24 with co-organizer @MaxKrummel, and discussing how academia & industry can align their efforts to develop effective myeloid cell targeted therapies for cancer.
Please, RT!!! 🚨DC lovers #DC2024Barcelona🚨 📅Abstract deadline approaching: SUBMIT NOW!!! 👇 dc2024barcelona.com/index.php/abst… 34 slots for short talks available + posters! Supported by: @SEinmunologia @SCImmunologia @EuMacDcSoc Sponsors: 🥇@miltenyibiotec 🥈@inmunotek 🥉@BioLegend
Come check it out next Monday!
more info on our upcoming talks at NYU and Columbia 👇
In the NYC/Philly area? Come learn about what's happening at @biorxivpreprint and SolvingFor! Join @MaxKrummel and @cshperspectives as they hit the road: NYU and Columbia on March 18th and UPenn on March 20th!
Very excited about this. Richard and I have a chance to share some pretty cool options to unleash science. Come check it out and try it out. Feels more like what we all came into science for… and a good product of all your collective minds.
Curious about academic publishing's future? Looking for open-access alternatives? Upcoming seminar at UPenn w/ @cshperspectives of @biorxivpreprint & @medrxivpreprint and @MaxKrummel from @SolvingForSci should be illuminating!💡 🕤3/20 10:30-11:30AM 📍CRB, Austrian Auditorium
I tried this out last week. It already feels much better as a reviewer when you are writing directly to the author and towards genuinely improving the quality of the science. It also is cognitively easier (and faster) to do a better job. This is going to be good.
Immunologists, are you stuck in peer review purgatory? 🕙 Or perhaps you're closing out the year with a new preprint! We've got the pilot for you! Sign up to share your preprint, and let's fix publishing together! solvingfor.org/dsdc-pilot
Hope you can join @MaxKrummel and I at the keystone meeting we have organized on Myeloid Targeting Strategies for Cancer Treatment, this May in Killarney! keysym.us/KSMyeloidTarge… #KSMyeloidTargets24
Are so-called 'M2-like' CD206+ macrophages immunosuppressive? On the contrary, we find that they are critical for T cell mediated anti-tumor immunity tinyurl.com/53xhxyke with @MaxKrummel @KenHu77 @KellyKersten8 @alexis_combes and others
‼️🚨Kick off your weekend with an intro to a new, journal-free system for publishing—developed by and for scientists—that we’re piloting with our friends in immunology. Feeling intrigued? fed-up? skeptical? rebellious? Come watch the pitch! 😎 zoom.us/meeting/regist…
Ten years ago, Miranda Broz first described rare CD103+ intratumoral DC (now:TucDC1) and their role in driving T cell responses. Here, @RayArja in the lab found the ID/signature of also-rare T cells that have exceptional effector responses. tinyurl.com/StarEffectors Formative.
An anchoring aspect of this work is that tumors get their immune archetypes from one of the many normal functions of the immune system. Tumor immunity is no longer simply about 'immunity' v. tolerance. Join the team to build on this understanding, build it up, knock it down.
🎉Our Cancer immune archetype perspective is on @NatureRevCancer's July cover!. We're seeking a #postdoc to unravel the cellular networks and gene programs behind these archetypes. If you're fueled by passion for immunology and oncology 👉t.ly/0C3bB Please RT🙏
Our lab (Krummellab.com) is hiring a bioinformatics-minded person for the Immune Archetypes project.See it here: immunox.ucsf.edu/careers or apply here: aprecruit.ucsf.edu/JPF04467 I'm so proud of our ambitious and professional crowd; join us in SF!
What a great thing for Seattle and the Allen Institute! We’ll miss Ananda in CA but we’re all also so happy for an awesome scientist, collaborator and person.
🎉Our Cancer immune archetype perspective is on @NatureRevCancer's July cover!. We're seeking a #postdoc to unravel the cellular networks and gene programs behind these archetypes. If you're fueled by passion for immunology and oncology 👉t.ly/0C3bB Please RT🙏
Passionate about driving scientific research and making an impact? We're hiring a Research Development Strategist & Grantwriter in the Bakar ImmunoX Initiative at UCSF. Apply now: lnkd.in/giyD6275
Join us! SolvingFor is open to new members! Our first campaigns are launching, our new hire starts soon, and new member orientations begin as soon as July 6. Learn more about what it means to be a member, and how to sign up: solvingfor.org/news-posts-dat…